Frontage Laboratories Inc has acquired Concord Biosciences, a preclinical contract research organization (CRO) located near Cleveland, Ohio (US).
Formerly known as Ricerca Biosciences LLC, Concord Bio supports the pharmaceutical, agricultural, chemical and animal health industries with drug safety, metabolism, bioanalytical, residue and environmental fate studies.
"We have committed to build a global CRO company with integrated services. The acquisition of Concord Biosciences is a significant step toward reaching our goal. The addition of Concord Bio to the Frontage family will enable us to provide pharmaceutical product development services from lead selection to IND-enabling studies to commercialization.
Frontage Laboratories Inc has acquired Concord Biosciences, a preclinical contract research organization (CRO) located near Cleveland, Ohio (US).
Formerly known as Ricerca Biosciences LLC, Concord Bio supports the pharmaceutical, agricultural, chemical and animal health industries with drug safety, metabolism, bioanalytical, residue and environmental fate studies.
"We have committed to build a global CRO company with integrated services. The acquisition of Concord Biosciences is a significant step toward reaching our goal. The addition of Concord Bio to the Frontage family will enable us to provide pharmaceutical product development services from lead selection to IND-enabling studies to commercialization.
No comments:
Post a Comment